NO984974L - Middel som forbedrer pulmonar sirkulasjon - Google Patents

Middel som forbedrer pulmonar sirkulasjon

Info

Publication number
NO984974L
NO984974L NO984974A NO984974A NO984974L NO 984974 L NO984974 L NO 984974L NO 984974 A NO984974 A NO 984974A NO 984974 A NO984974 A NO 984974A NO 984974 L NO984974 L NO 984974L
Authority
NO
Norway
Prior art keywords
pulmonary circulation
improve pulmonary
pulmonary
effect
circulation
Prior art date
Application number
NO984974A
Other languages
English (en)
Norwegian (no)
Other versions
NO984974D0 (no
Inventor
Hajimu Kurumatani
Mitsutaka Tamura
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO984974D0 publication Critical patent/NO984974D0/no
Publication of NO984974L publication Critical patent/NO984974L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984974A 1997-02-27 1998-10-26 Middel som forbedrer pulmonar sirkulasjon NO984974L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4436397 1997-02-27
PCT/JP1998/000801 WO1998037895A1 (fr) 1997-02-27 1998-02-26 Medicaments permettant d'ameliorer la circulation pulmonaire

Publications (2)

Publication Number Publication Date
NO984974D0 NO984974D0 (no) 1998-10-26
NO984974L true NO984974L (no) 1998-12-23

Family

ID=12689438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984974A NO984974L (no) 1997-02-27 1998-10-26 Middel som forbedrer pulmonar sirkulasjon

Country Status (7)

Country Link
EP (1) EP0925787A4 (fr)
KR (1) KR20000065039A (fr)
CN (1) CN1224354A (fr)
AU (1) AU6117398A (fr)
CA (1) CA2253717A1 (fr)
NO (1) NO984974L (fr)
WO (1) WO1998037895A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US8183286B2 (en) * 2006-11-16 2012-05-22 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza a viral infection
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
JP2021054725A (ja) * 2019-09-27 2021-04-08 学校法人日本医科大学 イヌ肺高血圧症治療薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931510B2 (ja) * 1979-09-03 1984-08-02 東レ株式会社 ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
DE3041601A1 (de) * 1980-10-31 1982-06-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
DE3322893A1 (de) * 1983-06-23 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
JP4062743B2 (ja) * 1995-02-27 2008-03-19 東レ株式会社 「肺性心治療剤」

Also Published As

Publication number Publication date
KR20000065039A (ko) 2000-11-06
CN1224354A (zh) 1999-07-28
EP0925787A4 (fr) 1999-12-01
AU6117398A (en) 1998-09-18
CA2253717A1 (fr) 1998-09-03
NO984974D0 (no) 1998-10-26
EP0925787A1 (fr) 1999-06-30
WO1998037895A1 (fr) 1998-09-03

Similar Documents

Publication Publication Date Title
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
NO20051987L (no) Behandling av soppinfeksjoner.
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
DE69722401D1 (de) Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods
BRPI0515600A (pt) formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose
WO1999046279A3 (fr) INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES
NO20052348L (no) Behandling av hemoragisk sjokk
WO2003062273A3 (fr) Traitement medical
DE69814394D1 (de) Verwendung von levobupivacain
WO1996024370B1 (fr) Solutions pharmaceutiques salines non organiques a administration endonasale d'une calcitonine
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
NO20004931L (no) Anvendelse av dexmedetomidin til sedering pÕ intensivavdeling
NO984974L (no) Middel som forbedrer pulmonar sirkulasjon
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
Lishner et al. Treatment of diabetic perforating ulcers (mal perforant) with local dimethylsulfoxide
EP1425047A4 (fr) Methode d'amelioration du transport d'oxygene par des globules rouges stockes
NO985571L (no) Legemiddel for autoimmunsykdommer
NO985908L (no) FremgangsmÕte til Õ behandle leversykdom og liknende indikasjoner med vasodilaterende midler
DK1331940T3 (da) Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
AU5158000A (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
Pandey et al. Protective effects of aprotinin on respiratory and cardiac abnormalities induced by Mesobuthus tamulus venom in adult rats
WO2006020912A3 (fr) Traitements pour l'insuffisance cardiaque congestive
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse